Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom
- PMID: 28994465
- PMCID: PMC5734628
- DOI: 10.1002/mp.12623
Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom
Abstract
Purpose: In longitudinal oncological and brain PET/CT studies, it is important to understand the repeatability of quantitative PET metrics in order to assess change in tracer uptake. The present studies were performed in order to assess precision as function of PET/CT system, reconstruction protocol, analysis method, scan duration (or image noise), and repositioning in the field of view.
Methods: Multiple (repeated) scans have been performed using a NEMA image quality (IQ) phantom and a 3D Hoffman brain phantom filled with 18 F solutions on two systems. Studies were performed with and without randomly (< 2 cm) repositioning the phantom and all scans (12 replicates for IQ phantom and 10 replicates for Hoffman brain phantom) were performed at equal count statistics. For the NEMA IQ phantom, we studied the recovery coefficients (RC) of the maximum (SUVmax ), peak (SUVpeak ), and mean (SUVmean ) uptake in each sphere as a function of experimental conditions (noise level, reconstruction settings, and phantom repositioning). For the 3D Hoffman phantom, the mean activity concentration was determined within several volumes of interest and activity recovery and its precision was studied as function of experimental conditions.
Results: The impact of phantom repositioning on RC precision was mainly seen on the Philips Ingenuity PET/CT, especially in the case of smaller spheres (< 17 mm diameter, P < 0.05). This effect was much smaller for the Siemens Biograph system. When exploring SUVmax , SUVpeak , or SUVmean of the spheres in the NEMA IQ phantom, it was observed that precision depended on phantom repositioning, reconstruction algorithm, and scan duration, with SUVmax being most and SUVpeak least sensitive to phantom repositioning. For the brain phantom, regional averaged SUVs were only minimally affected by phantom repositioning (< 2 cm).
Conclusion: The precision of quantitative PET metrics depends on the combination of reconstruction protocol, data analysis methods and scan duration (scan statistics). Moreover, precision was also affected by phantom repositioning but its impact depended on the data analysis method in combination with the reconstructed voxel size (tissue fraction effect). This study suggests that for oncological PET studies the use of SUVpeak may be preferred over SUVmax because SUVpeak is less sensitive to patient repositioning/tumor sampling.
Keywords: 3D Hoffman brain phantom; IQ NEMA phantom; PET/CT; phantom repositioning; repeatability; reproducibility.
© 2017 The Authors. Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.
Figures







Similar articles
-
EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data.Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4652-4660. doi: 10.1007/s00259-022-05919-1. Epub 2022 Jul 25. Eur J Nucl Med Mol Imaging. 2022. PMID: 35876867 Free PMC article.
-
Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.Med Phys. 2010 Nov;37(11):6035-46. doi: 10.1118/1.3499298. Med Phys. 2010. PMID: 21158315 Free PMC article.
-
Repeatability of 18 F-FDG PET radiomic features: A phantom study to explore sensitivity to image reconstruction settings, noise, and delineation method.Med Phys. 2019 Feb;46(2):665-678. doi: 10.1002/mp.13322. Epub 2018 Dec 28. Med Phys. 2019. PMID: 30506687 Free PMC article.
-
PET NEMA IQ Phantom dataset: image reconstruction settings for quantitative PET imaging.Data Brief. 2021 Jun 18;37:107231. doi: 10.1016/j.dib.2021.107231. eCollection 2021 Aug. Data Brief. 2021. PMID: 34195308 Free PMC article.
-
The need of a system phantom for quantitative hybrid nuclear imaging of PET/CT: A systematic review.Med J Malaysia. 2021 Jul;76(4):551-561. Med J Malaysia. 2021. PMID: 34305117
Cited by
-
Small lesion depiction and quantification accuracy of oncological 18F-FDG PET/CT with small voxel and Bayesian penalized likelihood reconstruction.EJNMMI Phys. 2022 Mar 26;9(1):23. doi: 10.1186/s40658-022-00451-5. EJNMMI Phys. 2022. PMID: 35348926 Free PMC article.
-
Towards guidelines to harmonize textural features in PET: Haralick textural features vary with image noise, but exposure-invariant domains enable comparable PET radiomics.PLoS One. 2020 Mar 16;15(3):e0229560. doi: 10.1371/journal.pone.0229560. eCollection 2020. PLoS One. 2020. PMID: 32176698 Free PMC article.
-
Prognostic Value of Multiple Manual Segmentation Methods for Diffuse Large B-Cell Lymphoma with 18F-FDG PET/CT.Curr Oncol. 2025 Jun 16;32(6):356. doi: 10.3390/curroncol32060356. Curr Oncol. 2025. PMID: 40558299 Free PMC article.
-
The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective.Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1219-1235. doi: 10.1016/j.ijrobp.2018.06.023. Epub 2018 Jun 30. Int J Radiat Oncol Biol Phys. 2018. PMID: 29966725 Free PMC article. Review.
-
Impact of PET data driven respiratory motion correction and BSREM reconstruction of 68Ga-DOTATATE PET/CT for differentiating neuroendocrine tumors (NET) and intrapancreatic accessory spleens (IPAS).Sci Rep. 2021 Jan 26;11(1):2273. doi: 10.1038/s41598-020-80855-4. Sci Rep. 2021. PMID: 33500455 Free PMC article.
References
-
- Dehdashti F, Siegel BA, Griffeth LK, et al. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2‐[F‐18]fluoro‐2‐deoxy‐D‐glucose. Radiology. 1996;200:243–247. - PubMed
-
- Hoekstra CJ, Hoekstra OS, Stroobants SG, et al. Methods to monitor response to chemotherapy in non‐small cell lung cancer with 18F‐FDG PET. J Nucl Med. 2002;43:1304–1309. - PubMed
-
- Hoekstra CJ, Paglianiti I, Hoekstra OS, et al. Monitoring response to therapy in cancer using [18F]‐2‐fluoro‐2‐deoxy‐D‐glucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med. 2000;27:731–743. - PubMed
-
- Krak NC, van der Hoeven JJ, Hoekstra OS, Twisk JW, van der Wall E, Lammertsma AA. Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods. Eur J Nucl Med Mol Imaging. 2003;30:674–681. - PubMed
-
- Aoki J, Watanabe H, Shinozaki T, et al. FDG‐PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol. 2003;32:133–138. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical